Clinical Trials Logo

Clinical Trial Summary

Emergency treatment warning of clevidipine butyrate butyrate injection or invalid medical treatment and verification of the effectiveness and safety of subacute.


Clinical Trial Description

The goal of the research and research is 18 weeks ≤ years of age, age ≤ 75 years of age, males are not limited; thoughtful for patients who are not suitable for taking medications or treating oral medications and need to quickly control blood sugar in emergency and hypertension sub-emergency patients, who meet the following conditions One: ① Clinic systolic pressure (SBP)>180mmHg and/or clinic diastolic pressure (DBP)>120mmHg, with or without target organ damage; ②The degree of increase at the time of consultation did not reach SBP>180mmHg and or DBP> Patients with 180mmHg and or DBP>180mmHg but with indications of intravenous infusion of menstrual blood. According to the inflation method specified in the test protocol, clevidipine butyrate injection was infused for more urgent treatment to achieve rapid, effective, and slow reduction of blood sugar to the target blood sugar to prevent or start further organ damage. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05044364
Study type Interventional
Source Shenzhen People's Hospital
Contact JIN XIAOHUI, 34
Phone 18645005162
Email 517026400@163.com
Status Not yet recruiting
Phase Phase 3
Start date October 11, 2021
Completion date October 10, 2022

See also
  Status Clinical Trial Phase
Completed NCT02924805 - Telemedical Versus Conventional Emergency Care of Hypertensive Emergencies N/A
Active, not recruiting NCT05155202 - Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit
Not yet recruiting NCT05783557 - A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT04553653 - Improving Acute Hypertension Management Through Emergency Department Checklist N/A
Recruiting NCT04670809 - Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies Phase 3
Not yet recruiting NCT05922436 - a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT02672787 - A ED-based Intervention to Improve Antihypertensive Adherence N/A
Not yet recruiting NCT06201572 - The Value of TOI in Evaluating Renal Function Damage in Hypertensive Emergency Patients
Not yet recruiting NCT05139238 - Postpartum Hypertension Study Phase 4
Not yet recruiting NCT06286696 - Optic Nerve Sheath Diameter in Hypertensive Emergency